ClinicalTrials.Veeva

Menu
C

Centro Regional Integrado de Oncologia | Fortaleza, Brazil

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Platinum
Anastrozole
Tamoxifen
Exemestane
INCMGA00012
Ipilimumab
Pertuzumab
Capecitabine
Leuprolide Acetate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 18 total trials

A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)

This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast ca...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) befor...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Placebo
Drug: Pemetrexed

The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants...

Active, not recruiting
Melanoma
Renal Cell Carcinoma (RCC)
Drug: INCB 99280 with Ipilimumab

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safe...

Enrolling
Aged
Locally Advanced Head and Neck Squamous Cell Carcinoma
Radiation: Radiation Therapy
Drug: NBTXR3

A Phase III, randomised, double-blind, placebo-controlled, multi-centre study to assess the efficacy of olaparib maintenance monotherapy in relapsed...

Active, not recruiting
Relapsed Ovarian Cancer
Following Complete or Partial Response to Platinum Based Chemotherapy
Drug: Placebo to match olaparib 300mg
Drug: Olaparib 300mg tablets

This is a phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 to suppress ovarian function in premenopausal women with HR+,...

Enrolling
Breast Cancer
Drug: Anastrozole Tablets
Drug: Tamoxifen

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metast...

Active, not recruiting
Metastatic Nonsquamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
Drug: Placebo
Drug: Paclitaxel

TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 in suppressing ovarian function in premenopausal...

Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets

This is a randomized, active-controlled, open-label study of pembrolizumab (Pembro) given prior to surgery and pembrolizumab in combination with stan...

Active, not recruiting
Head and Neck Neoplasms
Radiation: Radiotherapy 70 Gray/day
Biological: Pembrolizumab 200 mg

Trial sponsors

Merck Sharp & Dohme (MSD) logo
L
Incyte logo
T
AstraZeneca logo
E
N
Pfizer logo
Puma Biotechnology logo
Seagen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems